Daniel Geynisman
Fox Chase Cancer Center/ Temple University Health System

Last Updated On 4/19/2024 8:36:06 AM
This is a disclosure report of the user financial relationships with for-profit health care companies.
All relationships are considered compensated unless otherwise noted. Relationships are self-held unless otherwise noted.

Employment
No Relationships to Disclose

Leadership
No Relationships to Disclose

Stock and Other Ownership Interests
No Relationships to Disclose

Honoraria
Company: Targeted Oncology
Recipient: You

Consulting or Advisory Role
Company: Pfizer
Recipient: You
Company: Exelixis
Recipient: You
Company: AstraZeneca
Recipient: You
Company: Seattle Genetics/Astellas
Recipient: You
Company: Merck
Recipient: You
Company: Bristol-Myers Squibb
Recipient: You

Speakers' Bureau
No Relationships to Disclose

Research Funding
Company: Merck
Recipient: Your Institution
Company: Astellas Pharma
Recipient: Your Institution
Company: Harpoon therapeutics
Recipient: Your Institution
Company: Arvinas
Recipient: Your Institution
Company: CG Oncology
Recipient: Your Institution

Patents, Royalties, Other Intellectual Property
No Relationships to Disclose

Expert Testimony
No Relationships to Disclose

Travel, Accommodations, Expenses
No Relationships to Disclose

Other Relationship
No Relationships to Disclose

(OPTIONAL) Uncompensated Relationships
No Relationships to Disclose

(OPTIONAL) Open Payments Link
No Relationships to Disclose